Lenalidomide at Therapeutic and Supratherapeutic Doses Does Not Prolong QTc Intervals in the Thorough QTc Study Conducted in Healthy Men

by Chen, Nianhang, Ye, Ying, Liu, Liangang, Reyes, Josephine, Assaf, Mahmoud S, Kasserra, Claudia, Zhou, Simon, Palmisano, Maria
Published 2013

Population Pharmacokinetics of Pomalidomide

by Li, Yan, Xu, Yejun, Liu, Liangang, Wang, Xiaomin, Palmisano, Maria, Zhou, Simon
Published 2015

No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers

by Chen, Nianhang., Weiss, Daniel, Reyes, Josephine, Liu, Liangang, Kasserra, Claudia, Wang, Xiaomin, Zhou, Simon, Kumar, Gondi, Weiss, Lilia, Palmisano, Maria
Published 2014

Evaluation of CYP3A‐mediated drug–drug interactions with romidepsin in patients with advanced cancer

by Laille, Eric, Patel, Manish, Jones, Suzanne F., Burris, Howard A., Infante, Jeffrey, Lemech, Charlotte, Liu, Liangang, Arkenau, Hendrik‐Tobias
Published 2015

Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunt...

by Chen, Nianhang, Weiss, Daniel, Reyes, Josephine, Liu, Liangang, Kasserra, Claudia, Wang, Xiaomin, Zhou, Simon, Kumar, Gondi, Weiss, Lilia, Palmisano, Maria
Published 2014

The effects of apremilast on the QTc interval in healthy male volunteers: a formal, thorough QT study

by Palmisano, Maria, Wu, Anfan, Assaf, Mahmoud, Liu, Liangang, Park, C. Hyung, Savant, Ishani, Liu, Yong, Zhou, Simon
Published 2016